Both siRNA and pharmacological inhibitor (SJB3-019A) targeting USP1 can suppress ID1/AKT axis, inhibit B-ALL cell growth, and promote apoptosis [79]. This evidence concerns the gene ID1 and acute lymphoblastic leukemia.